How to buy Basilea Pharmaceutica AG (BPMUF) shares – Learn step by step

basel pharmaceutical ag

Basel Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on developing products that address medical needs in the therapeutic areas of oncology and anti-infectives. It offers CRESEMBA, an intravenous and oral azole antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, the European Union, and internationally, as well as in phase III clinical trials for invasive fungal infections in Japan. The company also supplies Zevtera, an antibiotic for the treatment of hospital-acquired and community-acquired pneumonia, as well as in phase III clinical trials for the treatment of acute bacterial skin and skin structure infections, and bacteremia. of Staphylococcus aureus in European and various non-European. countries. Besides, is involved in the development of DERATANTINIB, a small molecule inhibitor, which is in a Phase 2 clinical trial for bile duct cancer, as well as a Phase ½ clinical trial for bladder and stomach cancer; and lisavanbulin, a tumor control driver drug. The company was founded in 2000 and is based in Basel, Switzerland.

How to buy Basilea Pharmaceutica AG (BPMUF) shares – Learn step by step

Do you want to learn how to buy shares of Basilea Pharmaceutica AG (BPMUF) in OTC from Spain and using a regulated and reliable broker? Does it surprise you to be able to invest your earnings for the month and make profits on the stock market? Today I am going to show you how you can create an account at DEGIRO , a reliable German investment broker with low commissions, and how you can get your first shares in Basilea Pharmaceutica AG (BPMUF) (BPMUF) quickly and intuitively.

The method is easy to carry out :

  • First of all, we will register in Degiro, an interface in which we will pay for shares of the company Basilea Pharmaceutica AG (BPMUF) (BPMUF).
  • In 2nd place we will make a transfer of funds and execute our first investment.
  • Once we visualize the funds we have to search for Basilea Pharmaceutica AG by its Ticker, BPMUF.
  • To finish we must adjust the number of shares that we are going to buy, purchase value and type of order.

Perhaps the summary has been a bit simple for you, therefore I am going to explain the purchase process with images:

How to open your Degiro account

As a first step we must register in DEGIRO with this link :

buy shares of Basel Pharmaceutica AG (BPMUF)

It will require an e-mail, a username and a password to enter, and then we will continue through the link that they have sent us by email.

DEGIRO will continually request some important information from us in order to validate our documentation . We must have at hand our passport, national identity document or driving document, the telephone number and the bank account number that we will use to make our first deposit in IBAN format. If you do not understand what this format is like, you can review this simple tutorial that we have created at Educacep .

stock Basel Pharmaceutica AG

Once our account is approved we can put money from the Enter / Withdraw tab. We will be able to carry out a transaction that will take 1-3 days, or carry out the deposit quickly thanks to Sofort, a totally secure and very reliable payment gateway.

deposit money Basel Pharmaceutica AG

How to buy Basilea Pharmaceutica AG (BPMUF) shares via degiro

As soon as we have the capital we have the possibility of getting our 1st share. You can use the place order button in the upper right corner or use the DEGIRO search engine and put the ticker. In the next screenshot you will see that I have written the Amazon Ticker but you should enter (BPMUF), the Basilea Pharmaceutica AG ticker. As it is an action, we will perceive that the related results are listed and there we will discover Basilea Pharmaceutica AG. The fundamental thing is that the ticker, the name of the company and the market in which it is listed coincide. Amazon is listed on NASDAQ (NDQ) and in your case Basilea Pharmaceutica AG (BPMUF) is listed on OTC. This step is very fundamental so do not get confused.

American bidirectional bag Basilea Pharmaceutica AG

At the time of placing the order we will pay attention to the following . We may place a limit or market order. Imagine that you want to get a share of Basilea Pharmaceutica AG, but its price today is too high. With a limit order we will place the value at which we wish to carry out the operation and until there are no shares for sale at this value, the purchase operation of the share will not be executed. With a market order, you will buy the number of shares that we have suggested at the today’s selling price, which will be very close to the current trading price.

order at market price Basel Pharmaceutica AG (BPMUF)

In all cases it is important that you pay attention to the type of alignment: fixed or of the day . To give an example, in Spain, the stock market is in the morning until 1:00 p.m., and in the USA it corresponds to the afternoon schedule in Spain. If the order is fixed, it will remain until the point where it can be executed, but if you choose the “of the day” option, at the end of the day, if it is not executed, it will be deleted from your Activity tab – Orders in process .

I would love this detailed tutorial to help you invest in Basilea Pharmaceutica AG. THANK YOU.

  Company information
  • Basel Pharmaceutica AG (BPMUF) address: Grenzacherstrasse 487
    Basel 4058
    Switzerland
    41 61 606 11 11
    – Website: http://www.basilea.com
  • Ticker: BPMUF
  • Industry: Health Care
  • Industry: Employees
  • Number of employees: 160
  • Listed market: OTC

key executives

Name Title Salary exercised Year of birth
Mr David Veitch Executive Chief official 1.26M N/A 1965
Mr Adesh Kaul Chief Financial Officer N/A N/A 1974
Dr. Gerrit Hauck Ph.D. Chief Technology Officer N/A N/A 1964
Dr. Laurenz Kellenberger Ph.D. chief scientific officer N/A N/A 1967
Dr. Marc Engelhardt MD chief medical officer N/A N/A 1964
Dr Peer Nils Schroder Head of Corp. Communications Investor Relations N/A N/A N/A
Mr Damian Heller Gen. Counsel Corp. Sec. N/A N/A 1966
Ms. Ursula Eberhardt Head of Global HR N/A N/A 1962
Mr. Lutz Wevelsiep Head of Regulatory Affairs N/A N/A N/A
Mr. Dietrich Stüber Head of Internal Services N/A N/A N/A

Recent events of :

We have no recent events for this company.